Can the SpaceX IPO Move Korean Equities? Not a Liquidity Crisis, But an AI, Space and HBM Rebalancing Event
PharmaResearch Re-Rating Check: Can Rejuran Move From Medical Device Monopoly to U.S. Derma-Cosmetics Platform?